|
|
||||||||
Articles |
a Department of Molecular and Structural Biology, University of Aarhus, 8000 Aarhus C, Denmark
b Department of Clinical Biochemistry, Statens Serum Institut, 2300 Copenhagen S, Denmark
c Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905
d Department of Immunology and Medicine, Mayo Clinic, Rochester, Minnesota 55905
PAPP-A/proMBP, the complex of pregnancy-associated plasma protein-A (PAPP-A) and the proform of eosinophil major basic protein (proMBP), circulates at increasing levels during pregnancy. The major site of synthesis is the placenta, in which PAPP-A mRNA has been localized to the syncytiotrophoblast and the placental X cells, whereas proMBP mRNA has been localized to the placental X cells only. The function of PAPP-A/proMBP and its components has remained speculative for years. Recently, however, it has been shown that PAPP-A specifically cleaves insulin-like growth factor (IGF) binding protein-4 in an IGF-dependent manner. Female reproductive and nonreproductive tissues have previously been reported to contain PAPP-A immunoreactivity, based on studies using preparations of anti(PAPP-A/proMBP), now known to recognize both PAPP-A and proMBP, and other irrelevant antigens. To analyze for the presence of PAPP-A and proMBP mRNA, a sensitive semiquantitative reverse transcription (RT) polymerase chain reaction (PCR) method was developed. Reverse-transcribed poly(A)+ RNA was used as a template in a competitive PCR. PAPP-A and proMBP mRNA levels were normalized against the level of ß-actin mRNA. Both mRNA species were significantly more abundant in term placenta than in other tissues analyzed. All analyzed tissues, including endometrium, myometrium, colon, and kidney, contained both PAPP-A and proMBP mRNA.
2 Correspondence: Lars Sottrup-Jensen, Department of Molecular and Structural Biology, University of Aarhus, Gustav Wieds Vej 10C, 8000 Aarhus C, Denmark. FAX: 45 8612 3178; lsj{at}mbio.aau.dk
3 Current address: M&E Biotech A/S, Kogle Allé 6, 2970 Hørsholm, Denmark.
This article has been cited by other articles:
![]() |
H. Nishizawa, K. Pryor-Koishi, M. Suzuki, T. Kato, H. Kogo, T. Sekiya, H. Kurahashi, and Y. Udagawa Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients Mol. Hum. Reprod., October 1, 2008; 14(10): 595 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gyrup, M. Christiansen, and C. Oxvig Quantification of Proteolytically Active Pregnancy-Associated Plasma Protein-A with an Assay Based on Quenched Fluorescence Clin. Chem., May 1, 2007; 53(5): 947 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Glerup, S. Kloverpris, L. S. Laursen, F. Dagnaes-Hansen, S. Thiel, C. A. Conover, and C. Oxvig Cell Surface Detachment of Pregnancy-associated Plasma Protein-A Requires the Formation of Intermolecular Proteinase-Inhibitor Disulfide Bonds and Glycosaminoglycan Covalently Bound to the Inhibitor J. Biol. Chem., January 19, 2007; 282(3): 1769 - 1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Glerup, H. B. Boldt, M. T. Overgaard, L. Sottrup-Jensen, L. C. Giudice, and C. Oxvig Proteinase Inhibition by Proform of Eosinophil Major Basic Protein (pro-MBP) Is a Multistep Process of Intra- and Intermolecular Disulfide Rearrangements J. Biol. Chem., March 18, 2005; 280(11): 9823 - 9832. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Aso, K.-i. Okumura, S. Wakabayashi, K. Takebayashi, S. Taki, and T. Inukai Elevated Pregnancy-Associated Plasma Protein-A in Sera from Type 2 Diabetic Patients with Hypercholesterolemia: Associations with Carotid Atherosclerosis and Toe-Brachial Index J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5713 - 5717. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Boldt, K. Kjaer-Sorensen, M. T. Overgaard, K. Weyer, C. B. Poulsen, L. Sottrup-Jensen, C. A. Conover, L. C. Giudice, and C. Oxvig The Lin12-Notch Repeats of Pregnancy-associated Plasma Protein-A Bind Calcium and Determine Its Proteolytic Specificity J. Biol. Chem., September 10, 2004; 279(37): 38525 - 38531. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Laursen, M. T. Overgaard, K. Weyer, H. B. Boldt, P. Ebbesen, M. Christiansen, L. Sottrup-Jensen, L. C. Giudice, and C. Oxvig Cell Surface Targeting of Pregnancy-associated Plasma Protein A Proteolytic Activity. REVERSIBLE ADHESION IS MEDIATED BY TWO NEIGHBORING SHORT CONSENSUS REPEATS J. Biol. Chem., November 27, 2002; 277(49): 47225 - 47234. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hourvitz, A. Kuwahara, J. D. Hennebold, A. B. Tavares, H. Negishi, T. H. Lee, G. F. Erickson, and E. Y. Adashi The Regulated Expression of the Pregnancy-Associated Plasma Protein-A in the Rodent Ovary: A Proposed Role in the Development of Dominant Follicles and of Corpora Lutea Endocrinology, May 1, 2002; 143(5): 1833 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, A. Blanck, G. Norstedt, L. Sahlin, and A. Flores-Morales Identification of genes with higher expression in human uterine leiomyomas than in the corresponding myometrium Mol. Hum. Reprod., March 1, 2002; 8(3): 246 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mazerbourg, M. T. Overgaard, C. Oxvig, M. Christiansen, C. A. Conover, I. Laurendeau, M. Vidaud, G. Tosser-Klopp, J. Zapf, and P. Monget Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ovine, Bovine, Porcine, and Equine Ovarian Follicles: Involvement in IGF Binding Protein-4 Proteolytic Degradation and mRNA Expression During Follicular Development Endocrinology, December 1, 2001; 142(12): 5243 - 5253. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bayes-Genis, C. A. Conover, M. T. Overgaard, K. R. Bailey, M. Christiansen, D. R. Holmes Jr., R. Virmani, C. Oxvig, and R. S. Schwartz Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary Syndromes N. Engl. J. Med., October 4, 2001; 345(14): 1022 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Smith, A. Kamyar, W. Niu, J. Wang, B. Cercek, S. D. Chernausek, and J. A. Fagin IGF-Binding Protein-4 Expression and IGF-Binding Protein-4 Protease Activity Are Regulated Coordinately in Smooth Muscle During Postnatal Development and After Vascular Injury Endocrinology, October 1, 2001; 142(10): 4420 - 4427. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bayes-Genis, R. S. Schwartz, D. A. Lewis, M. T. Overgaard, M. Christiansen, C. Oxvig, K. Ashai, D. R. Holmes Jr, and C. A. Conover Insulin-Like Growth Factor Binding Protein-4 Protease Produced by Smooth Muscle Cells Increases in the Coronary Artery After Angioplasty Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 335 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christiansen, I. Jaliashvili, M. T. Overgaard, C. Ensinger, P. Obrist, and C. Oxvig Quantification and Characterization of Pregnancy-associated Complexes of Angiotensinogen and the Proform of Eosinophil Major Basic Protein in Serum and Amniotic Fluid Clin. Chem., August 1, 2000; 46(8): 1099 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Overgaard, J. Haaning, H. B. Boldt, I. M. Olsen, L. S. Laursen, M. Christiansen, G. J. Gleich, L. Sottrup-Jensen, C. A. Conover, and C. Oxvig Expression of Recombinant Human Pregnancy-associated Plasma Protein-A and Identification of the Proform of Eosinophil Major Basic Protein as Its Physiological Inhibitor J. Biol. Chem., September 29, 2000; 275(40): 31128 - 31133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Overgaard, H. B. Boldt, L. S. Laursen, L. Sottrup-Jensen, C. A. Conover, and C. Oxvig Pregnancy-associated Plasma Protein-A2 (PAPP-A2), a Novel Insulin-like Growth Factor-binding Protein-5 Proteinase J. Biol. Chem., June 8, 2001; 276(24): 21849 - 21853. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |